Lv1
70 积分 2023-02-09 加入
Systemic Lupus Erythematosus: A Review
2个月前
已完结
Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis
5个月前
已完结
Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors
5个月前
已完结
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis
7个月前
已完结
Comment on: “Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis”
7个月前
已完结
Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis
8个月前
已完结
Drug‐Induced Acute Pancreatitis: A Real‐World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database
8个月前
已完结
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for ramucirumab
8个月前
已完结
Immune-related adverse events in older adults: Data mining of the FDA Adverse Event Reporting System
9个月前
已完结
Signal mining of adverse reactions in the antiemetic drug ondansetron during pregnancy:A Real-World analysis of the FDA adverse Event Reporting System (FAERS)
10个月前
已完结
皖公网安备34019202002308
